Literature DB >> 2571258

An introduction to the pharmacology of alpha 2-adrenoceptors in the central nervous system.

M Scheinin, E MacDonald.   

Abstract

alpha 2-Adrenoceptors mediate a variety of physiological functions in the central nervous system and in peripheral tissues; thus, the use of pharmacological agents either activating or blocking these receptors results in a mixture of responses from several organs and tissues. This may be utilized therapeutically in some situations. In anaesthesiology, alpha 2-adrenergic agonists are already widely used as veterinary sedative-analgesics, and it is now clear that they are also capable of potentiating the effects and reducing the required dosage of other drugs used in anaesthesia (barbiturates, volatile anaesthetics, narcotic analgesics). In addition, they attenuate sympatho-adrenal responses to noxious stimuli encountered during anaesthesia and surgery, providing improved hemodynamic, metabolic and hormonal stability. Recent results from molecular biology, biochemistry and pharmacology point to the existence of distinct alpha 2-adrenoceptor subtypes. The identification of such subpopulations of alpha 2-adrenoceptors may provide new opportunities for the development of subtype-selective pharmacological agents with more specific therapeutic actions.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2571258

Source DB:  PubMed          Journal:  Acta Vet Scand Suppl        ISSN: 0065-1699


  9 in total

1.  Sedative and analgesic effects of medetomidine in beagle dogs infected and uninfected with heartworm.

Authors:  C S Venugopalan; E P Holmes; M P Crawford; M J Kearney; V Fucci
Journal:  Vet Res Commun       Date:  1998-02       Impact factor: 2.459

2.  Effects of epidural ketamine-xylazine combination on the clinicophysiological and haematobiochemical parameters of uraemic and healthy goats.

Authors:  K Singh; P Kinjavdekar; H P Aithal; A Gopinathan; G R Singh; A M Pawde; K Pratap
Journal:  Vet Res Commun       Date:  2006-12-23       Impact factor: 2.459

3.  The effects of idazoxan combined with 30% nitrous oxide on the jaw-opening reflex in the rat.

Authors:  O Nakanishi; T Ishikawa; T Hirakawa; K Hattori; M Nishi
Journal:  Anesth Prog       Date:  1997

4.  Neurohormonal and metabolic effects of medetomidine compared with xylazine in beagle dogs.

Authors:  T D Ambrisko; Y Hikasa
Journal:  Can J Vet Res       Date:  2002-01       Impact factor: 1.310

5.  Echocardiographic assessment of intravenous administration of medetomidine and xylazine hydrochloride at different sedative doses in one-humped camel calves (Camelus dromedarious).

Authors:  Mohammad Reza Esmailinejad; Majid Masoudifard; Omid Azari; Ehsanollah Sakhaee; Nima Ghalekhani
Journal:  Vet Res Forum       Date:  2022-03-15       Impact factor: 0.950

6.  Brain region and activity-dependent properties of M for calibrated fMRI.

Authors:  Christina Y Shu; Peter Herman; Daniel Coman; Basavaraju G Sanganahalli; Helen Wang; Christoph Juchem; Douglas L Rothman; Robin A de Graaf; Fahmeed Hyder
Journal:  Neuroimage       Date:  2015-10-31       Impact factor: 6.556

7.  Pulsed wave Doppler echocardiographic assessment after sedation by intravenous injection of medetomidine and xylazine hydrochloride on cardiac output and systolic time intervals in one-humped camel calves (Camelus dromedarious).

Authors:  M Masoudifard; M R Esmailinejad; E Sakhaee; O Azari; R Vafaei; N Ghalekhani
Journal:  Iran J Vet Res       Date:  2020       Impact factor: 1.376

8.  Detecting early kidney damage in horses with colic by measuring matrix metalloproteinase -9 and -2, other enzymes, urinary glucose and total proteins.

Authors:  Bela M Arosalo; Marja Raekallio; Minna Rajamäki; Elina Holopainen; Tuulia Kastevaara; Hanna Salonen; Satu Sankari
Journal:  Acta Vet Scand       Date:  2007-01-23       Impact factor: 1.695

9.  Evaluation of efficacy and safety of glycopyrrolate - xylazine - propofol anesthesia in buffalo calves.

Authors:  Sandeep Potliya; Ashok Kumar; Sandeep Kumar; Sukhbir Singh; Sarvan Kumar
Journal:  Vet World       Date:  2015-03-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.